Innovative NSAID dosage forms: lornoxicam suppositories and their standardization

Skupchenko, Viktoriya Viktorovna; Mekhonoshina, Ekaterina Nikolaevna

doi:10.33920/med-13-2110-06

Farmacevticheskoe Delo I Tehnologija Lekarstv (Pharmacy and Pharmaceutical Technology) 2021

DOI: 10.33920/med-13-2110-06

|View full text |Cite

Innovative NSAID dosage forms: lornoxicam suppositories and their standardization

Viktoriya Viktorovna Skupchenko

Ekaterina Nikolaevna Mekhonoshina²

Abstract: The article presents the studies on the development of a method for the quantitative determination of lornoxime in suppositories using UV spectrophotometry. The optical densities of the test solutions were recorded at a wavelength of 375 nm. The absorption spectra of standard solutions of lornoxicam, as well as of tested solutions of suppositories were obtained. The relative standard deviation was 2.31%.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Pharmaceutical Development: Rectal Dosage Forms - Lornoxicam – Microemulsion: Technology, Standardization Using a Standard Sample

Skupchenko

Степанова

E.B.³

2023

Mediko-farmacevtičeskij žurnal "Pulʹs"

View full text Add to dashboard Cite

Currently, the development of pharmaceutical science and industry, the introduction and development of evidence-based medicine dictate the need for a voluminous and at the same time careful attitude to the standardization of newly proposed original dosage forms. But any modern instrument variants require the use of a SS – standard capable of confirming the stability and expediency of the developed methodology. Therefore, this article focuses not only on technology and the choice of the optimal composition, but also on analytical support. In this paper, we have studied the possibility of obtaining a rectal dosage form of lornoxicam based on microemulsion by selecting the optimal composition that provides the necessary release of the active substance, as well as solving the issue of standardization of the dosage form using a standard sample.

show abstract

Pharmaceutical Development: Rectal Dosage Forms - Lornoxicam – Microemulsion: Technology, Standardization Using a Standard Sample

Skupchenko

Степанова

E.B.³

2023

Mediko-farmacevtičeskij žurnal "Pulʹs"

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Innovative NSAID dosage forms: lornoxicam suppositories and their standardization

Cited by 1 publication

References 5 publications

Pharmaceutical Development: Rectal Dosage Forms - Lornoxicam – Microemulsion: Technology, Standardization Using a Standard Sample

Pharmaceutical Development: Rectal Dosage Forms - Lornoxicam – Microemulsion: Technology, Standardization Using a Standard Sample

Contact Info

Product

Resources

About